Table 1.
Patient cohorts and diagnoses
| Pat.-ID | Tumour | Cachexia | Sex | Age | Diagnosis | BMI | Weight loss (% BW) |
|---|---|---|---|---|---|---|---|
| ctrl#1 | Ø | Ø | ♂ | 76 | Kidney donor | 28.7 | Ø |
| ctrl#2 | Ø | Ø | ♀ | 73 | Sigma diverticulosis | 26.1 | Ø |
| ctrl#3 | Ø | Ø | ♀ | 71 | Cholecystolithiasis | 22.3 | Ø |
| ctrl#4 | Ø | Ø | ♂ | 84 | Entero-cutaneous fistula | 20 | Ø |
| ctrl#5 | Ø | Ø | ♀ | 78 | Sigma diverticulosis | 21.5 | Ø |
| PnC#1 | + | Ø | ♂ | 62 | Gastric carcinoma | 27.9 | Ø |
| PnC#2 | + | Ø | ♂ | 67 | Colon carcinoma | 24.5 | Ø |
| PnC#3 | + | Ø | ♀ | 65 | Colon carcinoma | 33.3 | Ø |
| PnC#4 | + | Ø | ♂ | 67 | Colon carcinoma | 44.1 | Ø |
| PnC#5 | + | Ø | ♀ | 75 | Pancreas carcinoma | 24.2 | Ø |
| PnC#6 | + | Ø | ♂ | 62 | Pancreas carcinoma | 26.2 | Ø |
| PnC#7 | + | Ø | ♂ | 71 | Non-Hodgkin lymphoma | 25.7 | Ø |
| PnC#8 | + | Ø | ♀ | 71 | Pancreas carcinoma | 23.2 | Ø |
| PC#1 | + | + | ♀ | 80 | Colon carcinoma | 22.2 | 12.3 |
| PC#2 | + | + | ♂ | 74 | Lymphoma | 26.2 | 10.6 |
| PC#3 | + | + | ♀ | 81 | Colon carcinoma | 32.0 | 14.0 |
| PC#4 | + | + | ♀ | 42 | Pancreas carcinoma | 23.2 | + (n.d.) |
| PC#5 | + | + | ♂ | 66 | Pancreas carcinoma | 20.4 | + (n.d.) |
| PC#6 | + | + | ♀ | 74 | Pancreas carcinoma | 25.6 | 12 |
ctrl: control; PnC: non-cachectic tumour patient; PC: cachectic tumour patient.